Aequinetin
Aequinetin is a tyrosinase inhibitor, and docking results show that it forms hydrogen bonds and hydrophobic interactions with key protein residues of NF-κB p65, MAPK10 and ERK1.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 31025-53-3
- Formule: C21H20O9
- Masse moléculaire:416.38
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Aequinetin (chrysin 7-β-D-glucoside) is synthesized via in vitro enzymatic catalysis by glucosyltransferase from Phytolacca americana to perform site-specific glycosylation modification of Chrysin (HY-14589)[1].
Aequinetin exhibits stronger inhibitory activity against white mushroom tyrosinase than Chrysin[1].
Aequinetin docking results showed strong binding affinity to human NF-κB p65, MAPK10, and ERK1[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 31025-53-3
-
Masse moléculaire 416.38
-
Formule C21H20O9
-
SMILES
O=C1C2=C(O)C=C(O[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)CO)C=C2OC(C4=CC=CC=C4)=C1
-
Synonyms
Chrysin 7-β--D-glucoside
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)